A 3 month trial of the Oticon Tinnitus Sound Support feature in hearing aids for adults with hearing loss and tinnitus using the Tinnitus Functional Index as the primary outcome measure.

The University of Auckland0 sites40 target enrollmentDecember 22, 2021

ConditionsTinnitus Hearing loss (deafness)Ear - Other ear disorders Ear - Deafness

Overview

Phase: N/A
Intervention: Not specified
Conditions: Tinnitus
Sponsor: The University of Auckland
Enrollment: 40
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

Results confirm previous findings that hearing aids assist in reducing the impact of tinnitus on daily life. The Oticon miniRITE combination hearing aids used in this study resulted in similar improvements for new and existing hearing aid users. This suggests tinnitus-reducing effects of these aids was greater than those already being used by participants.

Registry

who.int

Start Date

December 22, 2021

End Date

December 12, 2022

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

The University of Auckland

Eligibility Criteria

Inclusion Criteria

•Inclusion criteria were: Adults aged 18 years or above; Chronic tinnitus (at least 6 months since onset); New and experienced HA users with a symmetric slight (16 dB HL) to moderately severe (70 dB HL) binaural symmetric (PTA4 difference between ears of 15 dB or less) sensorineural or mixed flat or sloping hearing loss; HA fitting level for the 60\- or 85\-dB speaker and domes, or custom moulds including all types and configurations of hearing loss; Scores in the range of ‘Normal to Severe’ in each of the three categories on the Depression Anxiety and Stress Scale – 21 Items (DASS 21\).